Cuprina (CUPR) stock dropped more than 7% on its Nasdaq debut Thursday, giving away gains from early in the day.
The Singapore-based biotechnology company priced an upsized $12 million initial public offering of 4 million class A ordinary share, up from initial plan of 3.75 million shares, at $4 each.
Cuprina shares opened at $4.40 just after 11:30 a.m. ET, up 10%, and quickly touched an intra-day high of $4.79 before dropping.
The company has granted underwriters an additional 450,000 shares as overallotment option. If the option is fully exercised, gross proceeds are expected to reach $13.80 million.
Cuprina plans to use net proceeds to fund its expansion into new markets in southeast Asia, Hong Kong, mainland China and the Middle East, research and development, brand awareness, equipment and infrastructure, and loan repayments.
Price: 3.70, Change: -0.30, Percent Change: -7.50
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.